EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:107736 - metoclopramide
| Formula | C14H22ClN3O2 |
| Net Charge | 0 |
| Average Mass | 299.802 |
| Monoisotopic Mass | 299.14005 |
| SMILES | CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC |
| InChI | InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19) |
| InChIKey | TTWJBBZEZQICBI-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | environmental contaminant Any minor or unwanted substance introduced into the environment that can have undesired effects. Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. xenobiotic A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. |
| Applications: | gastrointestinal drug A drug used for its effects on the gastrointestinal system, e.g. controlling gastric acidity, regulating gastrointestinal motility and water flow, and improving digestion. dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. antiemetic A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors. vulnerary A drug used in treating and healing of wounds. antidiarrhoeal drug Any drug found useful in the symptomatic treatment of diarrhoea. hyperglycemic agent A drug which increases the blood glucose level. vasoconstrictor agent Drug used to cause constriction of the blood vessels. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| metoclopramide (CHEBI:107736) has role analgesic (CHEBI:35480) |
| metoclopramide (CHEBI:107736) has role anti-HIV agent (CHEBI:64946) |
| metoclopramide (CHEBI:107736) has role antidiarrhoeal drug (CHEBI:55323) |
| metoclopramide (CHEBI:107736) has role antiemetic (CHEBI:50919) |
| metoclopramide (CHEBI:107736) has role antineoplastic agent (CHEBI:35610) |
| metoclopramide (CHEBI:107736) has role dopaminergic antagonist (CHEBI:48561) |
| metoclopramide (CHEBI:107736) has role environmental contaminant (CHEBI:78298) |
| metoclopramide (CHEBI:107736) has role gastrointestinal drug (CHEBI:55324) |
| metoclopramide (CHEBI:107736) has role hyperglycemic agent (CHEBI:76916) |
| metoclopramide (CHEBI:107736) has role vasoconstrictor agent (CHEBI:50514) |
| metoclopramide (CHEBI:107736) has role vulnerary (CHEBI:73336) |
| metoclopramide (CHEBI:107736) has role xenobiotic (CHEBI:35703) |
| metoclopramide (CHEBI:107736) is a benzamides (CHEBI:22702) |
| metoclopramide (CHEBI:107736) is a carbonyl compound (CHEBI:36586) |
| metoclopramide (CHEBI:107736) is a monochlorobenzenes (CHEBI:83403) |
| metoclopramide (CHEBI:107736) is a organic molecular entity (CHEBI:50860) |
| metoclopramide (CHEBI:107736) is a organohalogen compound (CHEBI:17792) |
| metoclopramide (CHEBI:107736) is a substituted aniline (CHEBI:48975) |
| metoclopramide (CHEBI:107736) is a tertiary amino compound (CHEBI:50996) |
| metoclopramide (CHEBI:107736) is conjugate base of metoclopramide(1+) (CHEBI:61170) |
| Incoming Relation(s) |
| metoclopramide(1+) (CHEBI:61170) is conjugate acid of metoclopramide (CHEBI:107736) |
| IUPAC Name |
|---|
| 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide |
| INNs | Source |
|---|---|
| metoclopramida | ChemIDplus |
| metoclopramide | ChemIDplus |
| metoclopramidum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide | ChemIDplus |
| 2-methoxy-5-chloroprocainamide | ChemIDplus |
| 4-amino-5-chloro-2-methoxy-N-(β-diethylaminoethyl)benzamide | ChemIDplus |
| 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide | ChemIDplus |
| 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide | ChEMBL |
| Clopra-"yellow" | ChEMBL |
| Brand Names | Source |
|---|---|
| Elieten | DrugBank |
| Reliveran | DrugBank |
| Citations |
|---|